Literature DB >> 10689371

[American cutaneous leishmaniasis in the State of Acre, Brazil].

N S Silva1, A B Viana, J A Cordeiro, C E Cavasini.   

Abstract

OBJECTIVE: Present a statistical survey of American Cutaneous Leishmaniasis (ACL) in the State of Acre.
METHODS: Data were obtained from the forms of the "Campaign against Leishmaniasis", from January 1992 to December 1997. Descriptive statistical analysis was applied.
RESULTS: There were 2.557 registered cases. The highest prevalence was found at the microregion of Brasiléia (231.8 cases/10,000 inhab.). The predominant clinical form was cutaneous (84.05%). The disease occurred mostly among males (71.02%). Half of the cases were among people with 24 years of age or younger. Most cases were people with rural occupations. 83.97% of the cases were diagnosed by clinical examination. The longest period to seek medical treatment was registered in the mesoregion of Juruá Valley (10.37 months)
CONCLUSION: The high number of cases suggests that it might be necessary to study the psychosocial implications of the disease and identify factors contributing to the delay in treatment.

Entities:  

Mesh:

Year:  1999        PMID: 10689371     DOI: 10.1590/s0034-89101999000600006

Source DB:  PubMed          Journal:  Rev Saude Publica        ISSN: 0034-8910            Impact factor:   2.106


  7 in total

1.  Mucocutaneous Leishmaniasis: clinical markers in presumptive diagnosis.

Authors:  João Luiz Cioglia Pereira Diniz; Manoel Otávio da Rocha Costa; Denise Utsch Gonçalves
Journal:  Braz J Otorhinolaryngol       Date:  2011-06

2.  MOLECULAR CHARACTERIZATION OF AMERICAN CUTANEOUS LEISHMANIASIS IN THE TRI‑BORDER AREA OF ASSIS BRASIL, ACRE STATE, BRAZIL.

Authors:  Carolina Bioni Garcia Teles; Jansen Fernandes Medeiros; Ana Paula de Azevedo dos Santos; Luís Antônio Rodrigues de Freitas; Tony Hiroshi Katsuragawa; Lilian Motta Cantanhêde; Ricardo de Godoi Mattos Ferreira; Luís Marcelo Aranha Camarg
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 Jul-Aug       Impact factor: 1.846

3.  Spatial and temporal distribution of American cutaneous leishmaniasis in Acre state, Brazil.

Authors:  Leonardo Augusto Kohara Melchior; Andréia Fernandes Brilhante; Francisco Chiaravalloti-Neto
Journal:  Infect Dis Poverty       Date:  2017-06-07       Impact factor: 4.520

4.  Epidemiological aspects of American cutaneous leishmaniasis (ACL) in an endemic area of forest extractivist culture in western Brazilian Amazonia.

Authors:  Andreia Fernandes Brilhante; Leonardo Augusto Kohatsu Melchior; Vânia Lúcia Brandão Nunes; Cristiane de Oliveira Cardoso; Eunice Aparecida Bianchi Galati
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2017-04-13       Impact factor: 1.846

5.  Socioenvironmental aspects of the Purus Region - Brazilian Amazon: Why relate them to the occurrence of American Tegumentary Leishmaniasis?

Authors:  Jorge Augusto de Oliveira Guerra; Maria das Graças Vale Barbosa Guerra; Zanair Soares Vasconcelos; Nayra da Silva Freitas; Fernanda Rodrigues Fonseca; Rubens Celso Andrade da Silva Júnior; Arineia Soares da Silva; Vanderson Sampaio; Marcel Gonçalves Maciel; Melissa de Sousa Melo Cavalcante; Bernardino Cláudio de Albuquerque; Gilton Mendes Dos Santos; Luiza Garnelo
Journal:  PLoS One       Date:  2019-02-07       Impact factor: 3.240

6.  Major environmental and socioeconomic determinants of cutaneous leishmaniasis in Brazil - a systematic literature review.

Authors:  Lia Puppim Buzanovsky; Manuel José Sanchez-Vazquez; Ana Nilce Silveira Maia-Elkhoury; Guilherme Loureiro Werneck
Journal:  Rev Soc Bras Med Trop       Date:  2020-06-01       Impact factor: 1.581

7.  Ecology, feeding and natural infection by Leishmania spp. of phlebotomine sand flies in an area of high incidence of American tegumentary leishmaniasis in the municipality of Rio Branco, Acre, Brazil.

Authors:  Márcia Moreira de Ávila; Andreia Fernandes Brilhante; Cristian Ferreira de Souza; Paula Dias Bevilacqua; Eunice Aparecida Bianchi Galati; Reginaldo Peçanha Brazil
Journal:  Parasit Vectors       Date:  2018-01-26       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.